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The effects of gold nanorods on the rate of apoptosis of triple
negative breast cancer cells

An Honors Thesis submitted in partial fulfillment of the requirements for Honors in
Biology

By
Mattie Elizabeth Raiford
Under the mentorship of Dr. Karin Scarpinato

ABSTRACT
Triple negative breast cancer (TNBC) is a subtype of breast cancer that is most
often found in African American females that is characterized by the lack of the
progesterone receptor (PR), the estrogen receptor (ER), and the human epithelial growth
factor receptor two (HER2).TNBC is a very aggressive form of breast cancer because it
does not respond to hormone therapy, due to the lack of the three vital receptors. Since
the current treatment is not affective, the project used porphyrin to specifically target
cancer in the body because it has an increased affinity for many cancer types. Gold
nanorods were used as a way to quickly heat the cells upon irradiation to kill the cells
with heat. The combination of the porphyrin and gold nanorods was thought to
selectively target the MDA cells and trigger apoptosis due to hyperthermic ablation once
exposed to IR irradiation.
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Objective
The objective of this study was to find a localized cancer treatment for triple
negative breast cancer that does not induce harm on the remaining, noncancerous parts of
the body. The specific aims of this study were (1) to identify whether gold nanorods
themselves have a negative impact on the apoptosis rate on triple negative breast cancer
cells after irradiation, (2) to determine the ideal concentration of gold nanorods to obtain
the highest level of apoptosis in triple negative breast cancer cells, and (3) to determine
the ideal time of irradiation to trigger the highest level of apoptosis.
Background
According to the National Cancer Institute, breast cancer is defined as a cancer
that is found in the tissues of the breasts in men and women: tumors are primarily located
in the ducts and lobules. Although breast cancer can occur in both men and women, it is
much more commonly found in women. Between the years 2005 and 2009, breast cancer
affected on average 122 women per 100,000 women in the United States for all races,
making it the leading cancer incidence in women for those years.[1] There are many
different types of breast cancer, and they can be classified by examining four different
characteristics: where they originate from in the breast, the stage of progression of the
cancer, the presence or absence of the PR, ER and HER2 protein receptors, and their
morphology. [2]
MDA-MB-231 is a breast cancer reprises the loss of the progesterone receptor
(PR), the estrogen receptor (ER), and the human epithelial growth factor receptor two
(HER2), as found in the triple negative breast cancer (TNBC).[3] TNBC is much more

difficult to treat than many other types of breast cancer because of the lack of the PR, ER,
and HER2 protein receptors. Since the current cancer therapies target these receptors, it
decreases the survival rate in patients with TNBC. TNBC is responsible for 10-15% of all
breast cancer cases in women.[4] TNBC and basal-like tumors are very similar in their
demographics. For example, both of the cancers commonly manifest themselves in
women under the age of 50, and they are more common in African American women
than any other race. They are also very aggressive types of breast cancer that have
approximately a 77% survival rate as compared to the 93% survival rate for many other
breast cancers over a five year period.[5] New therapies are needed to treat TNBC
effectively.
Nanotechnology is a scientific research field that utilizes the characteristics,
behaviors and structures of nanomaterials, particles that are between one and one hundred
nanometers in size. Nanomaterials generally differ from the element that they are derived
from. For example, gold nanoshells do not have the same physical properties as gold
does.[6] Nanomaterials currently have many research and medical applications. For
example, nanomaterials are used by drug industries in order to attach different ligands
that transform the nanomaterials into biosensors. One key property of nanomaterials is
that they can be easily conjugated with ligands, including those that have the potential to
distinguish between a diseased and normal cell.[6] This characteristic is important because
of its use in targeting cancerous cells without harming the normal cells in the area,
significantly reducing side effects of current chemotherapies. By changing the
morphology of the nanomaterials from spheres to rods, the absorption spectrum will be
changed from its original wavelength of visible light to a new wavelength of near infrared

which results in the wavelength infiltrating the human tissues much deeper than before.
Moreover, Jui-Teng
Teng et al and other demonstrate the use of gold nano
nanorods
rods in selective
photothermal therapy.[7]
Porphyrins are macrocyclic molecules that are composed of several benzyl rings
covalently linked.
nked. Porphyrins are of particular interest for new cancer therapies because
of their potential selectivity for cancer cells.[8] Porphyrin-conjugated
conjugated compound have
increased opportunities
tunities as agents for new cancer therapies because they absorb strongly
in the visible light spectrum, are non
non-toxic to cells, are stable complexes with in vivo
cancer affinity and are fluorescent. Porphyrins are suspected to have increased affinity for
cancer
ancer cells because the porphyrins have a ttendency
endency to aggregate in cancerous tissues[8].
Additionally, they can enter the tumor through the cell membrane or endocytosis.
Because porphyrin has a high affinit
affinity for serum proteins, they can gain
ain access into
vasculature,, which is altered and increased in tumors. Possibly making porphyrin
selective to cancer cells[8]. Combined with the gold nanorods, the porphyrin-conjugated
porphyrin
system can potentially target the breast cancer cells and destroy them based on the gold
nanorods’ ability to quickly heat up the cells.

Figure 1: (Left) The porphyrin conjugated ring system that will attach to the gold nanorods. (Right) The gold nanorods
that are conjugated to the porphyrin ring system in order to attach to the MDA cells.

Research Plan
Methods. The process of irradiating MDA-MB-231 cells with conjugated and
unconjugated gold nanorods is a four-day procedure.
Cell culture
The experiment was conducted using MDA-MB-231 cells. They were grown in a
monolayer using L-15 growth media supplemented with 10% FBS, penicillin and
streptomycin. They were maintained without carbon dioxide at 37° C.
Radiation
The MDA-MB-231 cells were planted on 96-well plates at a concentration of
12x104. Four plates were made: one unconjugated gold nanorods with cells without
radiation, one unconjugated gold nanorods with cells with radiation, one conjugated gold
nanorods with cells without radiation, and one conjugated gold nanorods with cells with
radiation. The gold nanorods were added at varying concentrations of 12 µL, 14 µL, 16
µL and 18 µL, and they were placed in the incubator for one hour. After incubation, the
wells were washed with PBS. The wells containing MDA-MB-231 cells are then
irradiated for two minutes per well.
MTS Assay

The MTS assay was added to the wells with MDA-MB-231 cells in all four of the
plates. The four plates were then placed one at a time in the spectrophotometer at 37

C.

If the average reading for each plate is not 1.2 OD, the plates must continue to be
incubated until the reading is 1.2 OD.
Implications
The effects of gold nanorods on triple negative breast cancer cells have
significance towards the development of new treatments for TNBC patients. A localized
treatment option for aggressive forms of breast cancer could benefit the patients by
targeting the specific area with cancer and not harming the noncancerous parts of the
body, reducing side effects. N techniques for the treatment of triple negative breast
cancer is important in counteracting the high death rate of this type of breast cancer that
is largely caused by the ineffective treatment with hormonal drugs or monoclonal
antibodies.[1]
Results
The MDA-MB-231 cells were irradiated using a near infrared laser at 785 nm for
varying times and nanorod concentrations. The project started with a power trail to see
the optimal decrease in cell viability. Figure 2 shows the percent of cell viability after
irradiation for 8 minutes at varying powers ranging from 140 to 200 mW. It was
determined that 140mW yielded the greatest amount of cell death after 8 minutes.
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Figure 2: The percent of cell viability of the MDA-MB-231 cells irradiated for 8 minutes at varying powers ranging
from 140 to 200 mW.

After the power that had the greatest cell death was determined. The MDA-MB231, trials were done to compare the percent of cell death of MDA-MB-231 cells with
and without radiation. It was hypothesized that the porphyrin would target the MDA-MB231 cells and that the gold nanorods would yield a greater amount of concentration heat
to the cells in order to trigger cell death. Figure 3 demonstrates the similarity between the
conjugated MDA-MB-231 cells that have been irradiated and those that have not been
exposed to radiation. The graph illustrates that cell death was not triggered in either the
conjugated MDA-MB-231 cells with radiation or those without radiation. The conjugated
MDA-MB-231 cells that were exposed to radiation should have shown increased cell
death because of the gold nanorods concentration the heat on the cells. Since the graph
illustrates that there is not a significant difference between the two conditions, it could
signify that the gold nanorods were not attached to the conjugated MDA-MB-231 cells.
Figure 3 was compared with Figure 4 to see if there was a difference in cell viability
between the conjugated MDA-MB-231 cells and the unconjugated MDA-MB-231 cells.

The conjugated MDA-MB-231 cells were exposed to porphyrin and the unconjugated
were not exposed to porphyrin. In theory, the conjugated MDA-MB-231 cells should
have had more cell death because the porphyrin should have shown affinity for the MDAMB-231 cells. However the graphs showed that there was 0% cell death in both the
conjugated and unconjugated cells,
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Figure 3: MDA-MB-231 cells. Cell viability after treatment with conjugated gold nanorods with and without radiation.
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Figure 4: MDA-MB-231 cells. Cell viability after treatment with unconjugated gold nanorods with and without
radiation.

The optimal concentration of gold nanorods was then determined by varying the
concentrations of conjugated and unconjugated nanorods in MDA-MB-231 cells. The
concentrations of the unconjuated nanorods ranged from 0.00945 nM to 0.01431 nM.
While the concentrations of conjugated nanorods varied from 0.0096 nM to 0.0144 nM.
Although this is a slight difference between the concentrations of nanorods between the
conjugated and the unconjugated MDA-MB-231 cells, it should not have been significant
enough to drastically change the percent of cell viability. Both of the graphs showed that
the greatest amount of apoptosis occurred around 0.01134 nM in unconjugated MDAMB-231 cells to 0.0112 nM in conjugated MDA-MB-231 cells that were irradiated.
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Figure 5: MDA-MB-231 cells. Cell viability at varying concentrations of unconjugated nanorods.
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Figure 6: MDA-MB-231 cells. Cell viability at varying concentrations of conjugated nanorods.

Discussion
At the start of the experiment, a power trail was done in order to find the power
that yielded the largest percentage of cell death. The trail concluded that for MDA-MB231 cells, the optimal power was 140 mW. Trials were done with MDA-MB-231 cells at
varying concentrations of gold nanorods to find the concentration that caused the most
cell death. The trails were done with conjugated and unconjugated gold nanorods. Two
plates were exposed to radiation and the other two were not irradiated. The results from
the conjugated nanorods showed that a concentration of 0.0112 nM killed the most
MDA-MB-231 cells. A concentration of 0.01134 nM triggered the most cell death in the
unconjugated nanorods. The results of the trials were then compared to determine if the
porphyrin was able to bind to the MDA-MB-231 cells for a specific treatment.
The project was not successfully completed in the allotted time due to many
reasons. The first probable reason for the failure of the project was the inappropriate laser
capacity in the Chemistry Department. The project relied on the laser being able to
generate enough heat to irradiate the targeted cells by increasing the energy in the

porphyrin conjugated rods. Since the laser was not able to obtain the optimal power
needed to induce to desired result, it is possible that the cells were not able to receive
sufficient radiation to trigger apoptosis. Figure 2 demonstrates that varying powers have
no effect on the cell viability of MDA-MB-231 cells. The most cell death at 140 mW.
Another possible reason for the failure to induce high levels of apoptosis could be
attributed to the lack of affinity of the porphyrin conjugated gold nanorods for the MDAMB-231. Figure 1 shows the structure of the porphyrin ring that is attached to the gold
nanorods. The amide to the far left is the portion of the porphyrin ring system that will
attach to the gold nanorod. Based on the literature, it was believed that the porphyrin rods
would have an affinity for the MDA-MB-231 cells[8]; however, Figures 3 and 4 implies
that the porphyrin has little to no affinity for the triple negative breast cancer cells
because there was close to 100% cell viability after irradiation at 785 nm after incubation
with the porphyrin nanorods. Additionally when the results from the porphyrin
conjugated rods were compared to that of the unconjugated rods, there was little
difference between them, as seen in Figures 3 and 4.
Both poor laser power and porphyrin’s lack of affinity for MDA-MB-231 cells
can be seen in Figures 5 and 6. Figure 5 shows the percentage of cell viability of MDAMB-231 cells at varying concentrations from 0.00945 to 0.01431 nM. Figure 6 illustrates
the percentage of cell viability at concentrations ranging from 0.0096 to 0.0144 nM. It
was expected for the cell viability to decrease as the concentration of gold nanorods
increased; however, Figures 5 and 6 showed that as the concentration increased, the cell
viability increased. This either supports that the porphyrin has little to no affinity for
MDA-MB-231 cells or that the power was not strong enough to induce apoptosis. It

could also suggest that the gold nanorods are not attaching to the cells, regardless of
whether the porphyrin is conjugated to the nanorods or not. There is also the possibility
that the rods aggregated instead of dispersing evenly between the cells. If it is necessary
for uptake, that could not happen. This would mean that many of the cells were not
getting the increased heat that the gold nanorods deliver, resulting in greater cell viability.
Gold nanorods are currently being used in cancer therapy research because they 1)
have the ability to increase the amount of damage to the cells caused by radiation and
drugs, and 2) generate heat when exposed to near-infrared radiation, which provides the
possibility to increase cell death by thermal ablation [13]. Near-infrared light is the best
type of radiation to use because of its ability to make a way into the deep tissues because
it is has low levels of absorption by bodily fluids [14]. Gold nanorods are used because
they are able to decrease the amount of light that results from interactions with
surrounding tissues. Because they limit the unnecessary light interactions in the
surrounding tissue areas, gold nanorods also limit the healthy tissue damage as a result of
radiation [14]. It has been published that cell death will occur when the irradiated sample
reaches 41°C-47°C using near-infrared light [15]. Hyperthermia results in the denaturing
of the cellular proteins which weakens the cellular membrane. Its use as a cancer therapy
is to inhibit tumor cell growth by means of triggering apoptosis in the tumor cells or
making the cells more susceptible to radiation or chemotherapy [15].
It is possible that this project was not irradiating the MDA-MB-231 cells long
enough to reach the necessary temperature to trigger apoptosis, or a more powerful laser
may have been needed to reach the target temperature range. The cells were irradiated
using less media in hopes of reaching a higher temperature; however, less media resulted

in the wells drying too quickly during the irradiation process. It has been suggested that
the pulsed-mode laser is the more suitable choice for cancer therapies because it allows
for more efficient photothermal conversion [14]. In the future the research could be
improved by discovering a way to 1) measure the temperature that irradiation with
nanorods is giving off compared to samples without nanorods, and 2) achieve the optimal
temperature without causing greater amount of cell death by stressing the cells due to the
decreased level of media. The project could also change the type of laser used to the
pulsed-mode laser in hopes of delivering more efficient and stronger beam to the MDAMB-231 cells.
Conclusion
Although this experiment did not yield the expected outcome, there is hope for the
future of localized breast cancer therapies. The particular porphyrin that was chosen for
use in this experiment is one type among many. In the future, some of the issues with this
experiment, such as a lack of affinity for the MDA-MB-231 cells by the porphyrin could
potentially be resolved by using a different type of porphyrin. The other major issue with
this experiment, the lack of power, could possibly be resolved by using a stronger laser
with less refraction over a longer period of time, in hopes of increasing the rate of cell
death.
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